Close
GS1 Global Healthcare Conference 2026
LiGHT 2026

Unilabs’ Patients get faster diagnosis of sepsis through the project SMARTDIAGNOS

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

WebMD Ignite Ruby Transforms Healthcare Marketing...

WebMD Ignite has announced the launch of WebMD Ignite...

Mayo Clinic Study Validates AI Tool...

Researchers at Mayo Clinic have found that an artificial...

MHRA Outlines New Agenda for AI...

The United Kingdom’s Medicines and Healthcare products Regulatory Agency...
Unilabs Sweden is a key player to the EU project "SMARTDIAGNOS- Next Generation sepsis diagnosis technology", which provides rapid diagnostics and better conditions for treatment for patients with blood poisoning.
 
Blood poisoning, known as sepsis, is a potentially fatal immune response of the human body, often caused by bacterial or fungal infection. Early diagnosis is crucial for proper treatment.
 
"Unilabs eagerly looks forward to contributing to this important project", says Helena Enroth, development manager Molecular Unilabs Skövde and adjunct professor at the University of Skövde.
 
Ten partners consisting of companies, institutions and universities, runs the SMARTDIAGNOS- project simultaneously. The 4-years running project has received funding from the EU's "Horizon 2020 Research and Innovation Programme under the grant agreement No. 687 697 ". The project started om February 1, 2016.
 
SMARTDIAGNOS will provide fast and accurate sepsis diagnosis, with the ability to reduce morbidity and mortality by up to 20%. 

Never miss a healthcare headline

Healthcare moves fast – stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Latest stories

Related stories

Mayo Clinic Study Validates AI Tool DEXI for Skin Lesion Assessment

Researchers at Mayo Clinic have found that an artificial...

MHRA Outlines New Agenda for AI Medical Devices at AdvaMed

The United Kingdom’s Medicines and Healthcare products Regulatory Agency...

UK Confirms Indefinite Use of CE Marked Medical Devices

The United Kingdom government has officially confirmed the indefinite...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »